Bioactive compounds, nutraceutical values and its application in food product development of oyster mushroom

Devi, Phuritshabam Vivekanandini; Islam, Jasmin; Narzary, Pameena; Sharma, Daisy; Sultana, Farhanaz

doi:10.1016/j.jfutfo.2023.11.005

Cited by 17 publications

(4 citation statements)

References 60 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Additionally, their quality and quantity are influenced by external conditions, such as environmental conditions or the micronutrients supplied during their growth [19]. In this context, EPSs are presented as a promising alternative for their application in various fields of bioproducts, with a particular emphasis on the pharmaceutical sector and clinical therapy [49,50]. This has also led to a surge in research activity over the past decade, as evidenced by a simple search in the ScienceDirect database using the keywords "exopolysaccharides" and "mushrooms".…”

Section: Exopolysaccharidesmentioning

confidence: 99%

Bioactive Compounds Produced by Macromycetes for Application in the Pharmaceutical Sector: Patents and Products

Martinez-Burgos,

Montes Montes,

Pozzan

et al. 2024

Fermentation

View full text Add to dashboard Cite

It is widely known that mushrooms present several properties with applications in the medicinal and pharmaceutical sectors, including antimicrobial, immunomodulatory, antioxidant, hypotensive, neuroprotective, and anti-inflammatory activities. This article aims to review examples of the bioactive metabolites responsible for those activities, such as polysaccharides, phenols and polyphenols, terpenes, peptides, alkaloids, and steroids, which are produced by several relevant mushroom species. It also discusses their production through solid-state fermentation and submerged fermentation, as well as the processes of obtention of mushroom bioactive extracts and considerations on their stability aiming industrial applications. In addition, the article examines the patent landscape surrounding mushroom-derived bioactives, shedding light on the intellectual property history and innovations driving this field forward. Examples of recently deposited patents in the field are highlighted, as well as the main depositors. China and the United States are the major depositor countries in this field (52% and 35% of patents, respectively), and the principal compounds on the patents are polysaccharides and alkaloids. The article also provides insights into the current market landscape, showcasing mushroom-derived products in the pharmaceutical field available to consumers. From dietary supplements to skincare formulations, the market offerings reflect the growing interest in harnessing the health benefits of mushroom bioactives.

show abstract

Section: Exopolysaccharidesmentioning

confidence: 99%

Bioactive Compounds Produced by Macromycetes for Application in the Pharmaceutical Sector: Patents and Products

Martinez-Burgos,

Montes Montes,

Pozzan

et al. 2024

Fermentation

View full text Add to dashboard Cite

show abstract

“…Moreover, despite having a 45% water content, SMS possesses a compact composition with a comparatively lower bulk density than manure [56]. Furthermore, extractive compounds presented in SMS are derived from fungal biomass (fungal mycelium), encompassing carbohydrates like β-glucans, as well as proteins and sterols [57], chitin-glucan complex, phenolics, and flavonoids [58], which can be extracted with conventional and modern techniques [57] and then used for their antimicrobial and prebiotic benefits in the food, pharmaceutical, and poultry industries [59]. Generally, there are some groups of bioactives that can be found in P. ostreatus, including polysaccharides, lovastatin, ergosterols and phytochemicals (Figure 1).…”

Section: The Environmental Importance Of Smsmentioning

confidence: 99%

Pleurotus ostreatus Mushroom: A Promising Feed Supplement in Poultry Farming

Törős,

El-Ramady,

Béni

et al. 2024

Agriculture

View full text Add to dashboard Cite

Pleurotus ostreatus (Jacq. ex Fr.) P. Kumm mushrooms are cultivated on diverse by-products based on substrates that hold promise for mitigating antibiotic usage in the poultry industry and reducing environmental pollution. By incorporating agricultural by-products into mushroom cultivation, the functionality of the mushroom products can be increased, then the final product can be a more effective feed supplement. After mushroom cultivation, spent mushroom substrate (SMS) can be valorized, due to the presence of huge amounts of bioactive compounds like β-glucan, chitin, polyphenols, and flavonoids related to mycelia. As a prebiotic and antimicrobial feed supplement, these mushrooms positively influence gut microbiota, intestinal morphology, and thus overall poultry well-being. This article underscores the potential of solid-state fermentation (SSF) to enhance the bioactivity of oyster mushrooms and their derivatives, offering a cost-effective and efficient strategy for transforming unconventional feeding materials. Moreover, it emphasizes broader implications, including the reduction of antibiotic dependence in poultry farming, highlighting the promising integration of oyster mushrooms and their derivatives for sustainable and environmentally conscious poultry production.

show abstract

“…These compounds serve as indicators or reference points for quality control and standardization of nutraceutical products (Morris;2001). The selection of standard compounds is typically based on their presence in the botanical source or their known bioactivity (Moreno et al 2006;Devi et al 2024). For the validation, it is imperative to ensure their safety, e cacy, and quality according to Association of O cial Analytical Collaboration (AOAC) international guidelines (2023).…”

Section: Introductionmentioning

confidence: 99%

Validation of an Analytical Methods of 3',4',5-Trihydroxy-3-Methoxy-6,7- Methylenedioxyflavone 4'-Glucuronide for Standardization of Spinacia oleracea

Son,

Jung,

Lee

et al. 2024

Preprint

View full text Add to dashboard Cite

Spinach (Spinacia oleracea) is one of the most famous vegetables worldwide, rich in essential metabolites for various health benefits. It is a valuable plant source that has the potential to be a nutraceutical. In the process of developing functional foods, it is crucial to establish a standard compound and quantitative analysis methods to ensure standardization. Thus, the analytical method validation was established using 3',4',5-trihydroxy-3-methoxy-6,7-methylenedioxyflavone 4'-glucuronide (TMG) as a marker compound. The specificity, accuracy, linearity, precision, repeatability, limit of detection (LOD), and limit of quantification (LOQ) was proved according to validation guideline. The specificity was confirmed from the BPI and UV chromatogram of the standard compound (TMG) as the predominant metabolite in the spinach sample. The calibration curve of TMG (15.625 ~ 500 µg/ml) had reasonable linearity (R2 = 0.999) considering with LOD and LOQ values, respectively. Recovery rate of TMG was 93.31-100.98% for FDS and 90.37–95.04% for SEC. The precision was less than 3 and 6% in the intra-day and inter-day. The spinach samples (FDS and SEC) were validated using TMC as a standard compound to comply with AOAC and KFDA regulations for approving functional ingredients in health functional food.

show abstract

Bioactive compounds, nutraceutical values and its application in food product development of oyster mushroom

Cited by 17 publications

References 60 publications

Bioactive Compounds Produced by Macromycetes for Application in the Pharmaceutical Sector: Patents and Products

Bioactive Compounds Produced by Macromycetes for Application in the Pharmaceutical Sector: Patents and Products

Pleurotus ostreatus Mushroom: A Promising Feed Supplement in Poultry Farming

Validation of an Analytical Methods of 3',4',5-Trihydroxy-3-Methoxy-6,7- Methylenedioxyflavone 4'-Glucuronide for Standardization of Spinacia oleracea

Contact Info

Product

Resources

About